1. A. The Prescription Drug Affordability Fund is a special, non-lapsing fund that is not subject to State Procurement Article, §7–302, Annotated Code of Maryland.

2. B. The Prescription Drug Affordability Fund consists of:

   1. (1) The assessment provided for by Regulation .02 of this chapter;
   2. (2) Money appropriated by the State budget;
   3. (3) Interest earnings; and
   4. (4) Any other money from any other source accepted for the benefit of the Fund.

Authority: Health-General Article, §§21-2C-03(f) and 21-2C-11, Annotated Code of Maryland

Effective date: September 6, 2021 (48:18 Md. R. 692)

Regulation .02 amended as an emergency provision effective November 16, 2021 (48:26 Md. R. 1107); emergency provision expired May 6, 2022

Regulation .02 amended effective August 22, 2022 (49:17 Md. R. 791); October 2, 2023 (50:19 Md. R 854)

Regulation .03 amended effective August 19, 2024 (51:16 Md. R. 743)

Regulation .03A amended effective October 2, 2023 (50:19 Md. R 854)

Regulation .03B amended as an emergency provision effective November 16, 2021 (48:26 Md. R. 1107); emergency provision expired May 6, 2022

Regulation .03B amended effective August 22, 2022 (49:17 Md. R. 791)